Shilpa Medicare shares surged by 3% after the company’s unit, Shilpa Pharma Lifesciences, received GMP certification from COFEPRIS, Mexico’s health authority. This certification follows a successful GMP inspection, marking a significant milestone for the company’s operations in the region.
As of 12:17 PM, Shilpa Medicare’s shares were trading at ₹663.95 on the NSE, up 3.19%.
TOPICS:
Shilpa Medicare